Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 103kWORD 24k
30 May 2015
Question for written answer E-008745-15
to the Commission
Rule 130
Iratxe García Pérez (S&D)

 Subject:  Discrimination and nutritional risks due to the high price of food for coeliac sufferers
 Answer in writing 

One in every 80-100 citizens has coeliac disease. Treatment consists of a strict gluten-free diet for life. Nevertheless, basic products for coeliac sufferers are considerably dearer than ordinary food.

According to a study by FACE (Spanish Federation of Coeliac Associations)(1), coeliac sufferers may find that their shopping basket costs an additional EUR 1 500 per year — 265% more than an ordinary shop.

There are considerable differences in the aid Member States give to coeliac sufferers — such as gluten-free products available free of charge for children and the elderly, refunds for patients against production of the labels from purchased products, social security benefits, etc. — whereas in countries like Spain there is no support of any kind for those affected.

The Commission has helped to pass effective legislation on labelling and consumer information, but did not respond to calls from the European Parliament during the previous legislature to reduce the discrimination involved in the high prices of these products.

Has the Commission carried out any kind of study or does it have any data on the extent to which prices are a factor in worsening the health of the coeliac population?

What steps can it take in this regard?


Original language of question: ES 
Legal notice